In November, the U.S. Food and Drug Administration issued an Emergency Use Authorization to allow the use of monoclonal antibodies for the treatment of mild to moderate symptoms of COVID-19 in adults and pediatric patients.
Physicians are encouraged to contact sites directly for additional information if they have patients who may benefit from this therapy and meet the criteria set by FDA and the entity administering the infusion.
The Arkansas Medical Society is here to serve our physician members and their medical teams. On our website, we have a place that you can send us questions or share what you're experiencing. Visit ARKMED.org/covid19 and click on the Got Questions box. We will respond to your question as soon as possible. Thank you for your hard work and together we will make it through this crisis.
